Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G (2018) Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 5:77–106. https://doi.org/10.1016/j.gendis.2018.05.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu F, Quan F, Xu J, Zhang Y, Xie Y, Zhang J, Lan Y, Yuan H, Zhang H, Cheng S, Xiao Y, Li X (2019) Breast cancer prognosis signature: linking risk stratification to disease subtypes. Brief Bioinform 20:2130–2140. https://doi.org/10.1093/bib/bby073

Article  CAS  PubMed  Google Scholar 

Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell 19:491–505. https://doi.org/10.1016/j.devcel.2010.09.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park Y, Park J, Lee Y, Lim W, Oh BC, Shin C, Kim W, Lee Y (2011) Mammalian MST2 kinase and human salvador activate and reduce estrogen receptor alpha in the absence of ligand. J Mol Med 89:181–191. https://doi.org/10.1007/s00109-010-0698-y

Article  CAS  PubMed  Google Scholar 

Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP (2017) Risk factors and preventions of breast cancer. Int J Biol Sci 13:1387–1397. https://doi.org/10.7150/ijbs.21635

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu L, Yang X (2018) Targeting the hippo pathway for breast cancer therapy. Cancers (Basel). https://doi.org/10.3390/cancers10110422

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Pan D (2019) The Hippo signaling pathway in development and disease. Dev Cell 50:264–282. https://doi.org/10.1016/j.devcel.2019.06.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D (2007) Elucidation of a universal size-control mechanism in drosophila and mammals. Cell 130:1120–1133. https://doi.org/10.1016/j.cell.2007.07.019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fallahi E, O’Driscoll NA, Matallanas D (2016) The MST/hippo pathway and cell death: a non-canonical affair. Genes 7:28

Article  PubMed  PubMed Central  Google Scholar 

Oka T, Mazack V, Sudol M (2008) Mst2 and lats kinases regulate apoptotic function of yes kinase-associated protein (YAP)*. J Biol Chem 283:27534–27546. https://doi.org/10.1074/jbc.M804380200

Article  CAS  PubMed  Google Scholar 

Ni L, Li S, Yu J, Min J, Brautigam Chad A, Tomchick Diana R, Pan D, Luo X (2013) Structural basis for autoactivation of human Mst2 kinase and its regulation by RASSF5. Structure 21:1757–1768. https://doi.org/10.1016/j.str.2013.07.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson BJ, Sahai E (2015) MST kinases in development and disease. J Cell Biol 210:871–882. https://doi.org/10.1083/jcb.201507005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao B, Lei QY, Guan KL (2008) The Hippo–YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20:638–646. https://doi.org/10.1016/j.ceb.2008.10.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turunen SP, von Nandelstadh P, Öhman T, Gucciardo E, Seashore-Ludlow B, Martins B, Rantanen V, Li H, Höpfner K, Östling P, Varjosalo M, Lehti K (2019) FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis. Cell Death Differ 26:2577–2593. https://doi.org/10.1038/s41418-019-0321-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Li J, Gao Y, Luo Y, Luo H, Wang L, Yi Y, Yuan Z, Jim Xiao Z-X (2019) Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress. Redox Biol 26:101233. https://doi.org/10.1016/j.redox.2019.101233

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin XY, Cai FF, Wang MH, Pan X, Wang F, Cai L, Cui RR, Chen S, Biskup E (2017) Mammalian sterile 20-like kinase 1 expression and its prognostic significance in patients with breast cancer. Oncol Lett 14:5457–5463. https://doi.org/10.3892/ol.2017.6852

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550. https://doi.org/10.1073/pnas.0506580102

Article  CAS  PubMed  PubMed Central  Google Scholar 

McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA, Wheeler AJ (2014) Using the nominal group technique: how to analyse across multiple groups. Health Serv Outcomes Res Method 14:92–108. https://doi.org/10.1007/s10742-014-0121-1

Article  Google Scholar 

Chen B, Chan WN, Mui CW, Liu X, Zhang J, Wang Y, Cheung AHK, Chan AKY, Chan RCK, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, Wong CC, Wu WKK, Cheng ASL, Yu J, Lo KW, To KF, Kang W (2021) STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker. Mol Cancer 20:147. https://doi.org/10.1186/s12943-021-01451-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liberzon A, Birger C, Ghandi M, Jill P, Tamayo P, Jolla L, Jolla L (2015) The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1:417–425

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Iny Stein T, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran MD (2016) Lancet, the genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform 1.30.1-1.30.33

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov Jill P, Tamayo P (2015) The molecular signatures database hallmark gene set collection. Cell Syst 1:417–425. https://doi.org/10.1016/j.cels.2015.12.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Q, Chang JT, Geradts J, Neckers LM, Haystead T, Spector NL, Lyerly HK (2012) Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res 14:R62. https://doi.org/10.1186/bcr3168

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou L, Chen M, Wang M, Cui X, Gao Y, Xing T, Li J, Deng S, Hu J, Yang H, Jiang J (2016) Systematic analyses of key genes and pathways in the development of invasive breast cancer. Gene 593:1–12. https://doi.org/10.1016/j.gene.2016.08.007

Article  CAS  PubMed  Google Scholar 

Issac MSM, Yousef E, Tahir MR, Gaboury LA (2019) MCM2, MCM4, and MCM6 in breast cancer: clinical utility in diagnosis and prognosis. Neoplasia 21:1015–1035. https://doi.org/10.1016/j.neo.2019.07.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park S, Brugiolo M, Akerman M, Das S, Urbanski L, Geier A, Kesarwani AK, Fan M, Leclair N, Lin K-T, Hu L, Hua I, George J, Muthuswamy SK, Krainer AR, Anczuków O (2019) Differential functions of splicing factors in mammary transformation and breast cancer metastasis. Cell Rep 29:2672-2688.e2677. https://doi.org/10.1016/j.celrep.2019.10.110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schirmer AU, Driver LM, Zhao MT, Wells CI, Pickett JE, O’Bryne SN, Eduful BJ, Yang X, Howard L, You S, Devi GR, DiGiovanni J, Freedland SJ, Chi JT, Drewry DH, Macias E (2022) Non-canonical role of hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. Mol Ther 30:485–500. https://doi.org/10.1016/j.ymthe.2021.08.029

Article  CAS  PubMed  Google Scholar 

Seidel C, Schagdarsurengin U, Blümke K, Würl P, Pfeifer GP, Hauptmann S, Taubert H, Dammann R (2007) Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog 46:865–871. https://doi.org/10.1002/mc.20317

Article  CAS  PubMed  Google Scholar 

Wang X, Wang F, Zhang ZG, Yang XM, Zhang R (2020) STK3 Suppresses ovarian cancer progression by activating NF-κB signaling to recruit CD8(+) T-cells. J Immunol Res 2020:7263602. https://doi.org/10.1155/2020/7263602

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park J, Kim GH, Lee J, Phuong BTC, Kong B, Won JE, Won GW, Lee YH, Han HD, Lee Y (2020) MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer. Toxicol Appl Pharmacol 408:115257. https://doi.org/10.1016/j.taap.2020.115257

Article  CAS  PubMed  Google Scholar 

Jia W, Chen P, Cheng Y (2019) PRDX4 and its roles in various cancers. Technol Cancer Res Treat 18:1533033819864313. https://doi.org/10.1177/1533033819864313